Type 2 diabetes can be controlled by high-strength probiotics (those containing > 10 billion CFU per dose) providing they contain clinically-studied strains for this purpose.

The object is to rebalance a diabetic person’s intestinal flora which has changed from that of a non-diabetic person.

A diabetic's flora contains a disproportionate amount of Bacteroides bacteria compared to Lactobacillus bacteria, and this contributes to decreased insulin sensitivity (1).